Cue Biopharma Ownership | Who Owns Cue Biopharma?

Overview Forecast RevenueFinancials Chart Transcripts

Cue Biopharma Ownership Summary

Cue Biopharma is owned by 27.92% institutional investors, 0.55% insiders, and 71.53% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 5.78% of CUE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.24% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cue Biopharma	27.92%	0.55%	71.53%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bleichroeder lp	2.86M	5.78%	$3.55M
Slate path capital lp	2.40M	4.86%	$2.98M
Vanguard group	2.03M	4.11%	$2.52M
Blackrock	756.74K	1.53%	$938.35K
Millennium management	493.99K	1.00%	$612.54K
Geode capital management	492.46K	1.00%	$610.79K
Robertson stephens wealth management	478.50K	0.97%	$593.34K
Northern trust	350.42K	0.71%	$434.52K
Good life advisors	325.00K	0.66%	$403.00K
Gsa capital partners llp	277.56K	0.56%	$344.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bleichroeder lp	2.86M	1.06%	$3.55M
Advisory research	257.23K	0.06%	$318.96K
Slate path capital lp	2.40M	0.06%	$2.98M
Good life advisors	325.00K	0.03%	$403.00K
Robertson stephens wealth management	478.50K	0.03%	$593.34K
Gsa capital partners llp	277.56K	0.02%	$344.00K
Point72 asia (singapore) pte.	53.03K	0.01%	$65.75K
Sigma planning	266.03K	0.01%	$329.88K
Legacy capital group california	10.00K	0.00%	$12.40K
Seacrest wealth management	13.00K	0.00%	$16.12K

Top Buyers

Holder	Shares	% Assets	Change
Good life advisors	325.00K	0.03%	225.00K
Goldman sachs group	266.37K	0.00%	220.74K
Millennium management	493.99K	0.00%	131.90K
Bleichroeder lp	2.86M	1.06%	106.58K
Jane street group	98.61K	-	98.61K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	756.74K	-	-1.49M
State street	177.05K	-	-582.74K
Geode capital management	492.46K	0.00%	-346.07K
Renaissance	-	-	-274.03K
Monaco asset management sam	-	-	-253.19K

New Positions

Holder	Shares	% Assets	Change	Value
Qube research	80.23K	0.00%	80.23K	$99.49K
Point72 asia (singapore) pte.	53.03K	0.01%	53.03K	$65.75K
Point72 (difc)	11.53K	0.00%	11.53K	$14.29K
Cubist systematic strategies	4.15K	-	4.15K	$5.14K
Newedge advisors	2.55K	-	2.55K	$3.16K

Sold Out

Holder	Change
Assetmark	-2.00
Nelson, van denburg & campbell wealth management group	-7.00
Farther finance advisors	-43.00
Innealta capital	-49.00
Kelly financial services	-500.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	75	-5.06%	13,812,235	-15.72%	27	2.18%	34	47.83%	20	-28.57%
Mar 31, 2024	79	-7.06%	16,389,056	10.09%	35	3.47%	23	-37.84%	28	47.37%
Dec 31, 2023	85	7.59%	14,886,637	6.22%	32	3.28%	37	8.82%	19	18.75%
Sep 30, 2023	79	-1.25%	14,014,945	1.19%	31	3.25%	34	-34.62%	16	77.78%
Jun 30, 2023	80	25.00%	13,849,912	14.89%	31	4.26%	52	116.67%	9	-47.06%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.35M	2.24%	-
Vanguard Institutional Extnd Mkt Idx Tr	597.57K	0.99%	-
Fidelity Extended Market Index	285.27K	0.47%	-1.15K
iShares Micro-Cap ETF	110.81K	0.18%	-
NT R2000 Growth Index Fund - NL	103.76K	0.17%	-
BlackRock Extended Equity Market K	103.23K	0.17%	-44.00
NT R2000 Index Fund - NL	89.94K	0.15%	-9.65K
Fidelity Total Market Index	82.40K	0.14%	-
NT R2000 Growth Index Fund - L	78.95K	0.13%	8.49K
Northern Trust Russell 2000 Growth Index	78.95K	0.13%	8.49K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 25, 2023	Suri Anish	PRESIDENT AND CSO	Buy	$11.04K
Aug 14, 2023	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	$8.58K
Mar 23, 2023	Kiener Peter A	-	Sell	$30.59K
May 27, 2022	Morich Frank		Buy	$105.00K
May 23, 2022	Fletcher Aaron G.L.		Buy	$183.70K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	2	-
2023 Q2	-	-

CUE Ownership FAQ

Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 27.92%, followed by 0.55% insiders and 71.53% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 45.43%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (2.86M shares, 5.78%), Slate path capital lp (2.4M shares, 4.86%), and Vanguard group (2.03M shares, 4.11%). Together, they hold 14.75% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Bleichroeder lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 1.06% of its assets in 2.86M Cue Biopharma shares, valued at 3.55M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cue Biopharma shares, with 2.24% of its total shares outstanding invested in 1.35M Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools